Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
INACTIVE COMPANY
 
My Lists

Galileo Pharmaceuticals

5301 Patrick Henry Drive
Santa Clara, CA 95054
USA
(408)-654-5830
Website Company Summary Management Team
Team

Management: Julie Dove (Director of Finance & Accounting);  Lisa Zanetto (Director of Human Resources)
Outside board: Guy Miller (BioElectron Technology CEO) Louis G. Lange (CV Therapeutics CEO);  Zoltan Bognar (Inventages Venture Capital);  Roy Cosan (Johnson & Johnson Development Corp);  Frederick B. Craves (Bay City Capital) David Milligan (Bay City Capital);  Peter Morris (Procter & Gamble);  Craig C. Taylor (Alloy Ventures) Gunnar Weikert (Inventages Venture Capital GmbH)
Company

Business description: Galileo Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of therapeutics for ischemic and inflammatory diseases. Galileo has programs in acute and chronic neurocognitive dysfunction and in systemic inflammatory disorders. The Company is targeting a novel class of vital, highly conserved enzymes using its proprietary Chemi-BiologicsTM drug discovery platform.
Capital

Rounds: 7
Recent fundings: Mar 2003   Oct 2000
Capital raised: 70.0M
Last Round: 32.0M
Ownership: Private  
VCs include: Adams Street PartnersAlloy VenturesBay City CapitalHambrechtAndQuist Capital ManagementPresidio PartnersSofinnova InvestmentsVantagePoint Capital Partners;  Brinson Partners;  Inventages Venture Capital;  North American Nutrition and Agribusiness Fund;  North Castle Partners;  The Chatterjee Group;  Trefoil S.A.

Last Tweets


 

Last Mentions


Overview
Record updated: Jul 2006
Sector: Biotech
Year Founded: 1995
Rounds: 7
Recent fundings: Mar 2003   Oct 2000
Capital raised: 70.0M
Last Round: 32.0M
Ownership: Private